This summary was created by AI, based on 1 opinions in the last 12 months.
According to experts, Marsh & McLennan's reinsurance and consulting businesses are expected to drive growth, especially with the recent acquisition. The company has the potential to achieve double-digit returns over the cycle. Analysts have set a price target of $201.35 for the stock, indicating positive prospects for investors.
It consistently earns, a good company. Buy some now and buy some more cheaper.
Marsh & McLennan is a American stock, trading under the symbol MMC-N on the New York Stock Exchange (MMC). It is usually referred to as NYSE:MMC or MMC-N
In the last year, there was no coverage of Marsh & McLennan published on Stockchase.
Marsh & McLennan was recommended as a Top Pick by on . Read the latest stock experts ratings for Marsh & McLennan.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Marsh & McLennan In the last year. It is a trending stock that is worth watching.
On 2025-01-14, Marsh & McLennan (MMC-N) stock closed at a price of $213.37.
Their reinsurance business increases when premiums increase. Also operate consulting businesses. Recently bought it. Expects double-digit returns over the cycle.
(Analysts’ price target is $201.35)